Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Signalling in T1DM with Insulin Withdrawal and GH
NCT02077348Completed
- Sponsor
- Aarhus University
- Start
- May 2014
- Primary completion
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of regular human insulin and somatropin in type 1 diabetes mellitus (T1D) (3 arms), sponsored by Aarhus University. Primary endpoints: Change in phosphorylation of intracellular target proteins and Change in mRNA expression of target genes. Started May 2014; status: completed.
02
Drugs
regular human insulinsomatropin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02077348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02077348.